Laboratory predictors of dengue shock syndrome during the febrile stage

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 2, 2010, Pages 326-332

  Chuansumrit, Ampaiwan ^a   Puripokai, Chartchai ^a   Butthep, Punnee ^b   Wongtiraporn, Wanida ^a   Sasanakul, Werasak ^a   Tangnararatchakit, Kanchana ^a   Chunhakan, Sirichan ^b   Yoksan, Sutee ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dengue hemorrhagic fever; Dengue shock syndrome; Predictors

Indexed keywords

ADOLESCENT; BLOOD; CHI SQUARE DISTRIBUTION; CHILD; DENGUE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; SEROLOGY; SYNDROME;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEROLOGIC TESTS; SEVERE DENGUE; STATISTICS, NONPARAMETRIC; SYNDROME;

EID: 77956018135     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bartlett A, Dormandy KM, Hawkey CM, Stableforth P, Voller A. Factor VIII related antigen: measurement by enzyme immunoassay. Br Med J 1976;1:994-6.
2. Basuki PS. A glance at the von Willebrand factor in dengue virus infection. Southeast Asian J Trop Med Public Health 2003;34:559-63.
3. Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat P, Chuansumrit A. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J 2006;25:894-7.
4. Cejka J. Enzyme immunoassay for factor VIII-related antigen. Clin Chem 1982;28:1356-8.
5. Funahara Y, Okawa K, Nobuya F, Yoshinobu O. Three possible triggers to induce thrombocytopenia in dengue virus infection. Southeast Asian J Trop Med Public Health 1987;18:351-5.
6. Gibbons RV. Dengue: an escalating problem. BMJ 2002;324:1563-6.
7. Kalayanaroj S. Standardized clinical management: evidence of reduction of dengue haemorrhagic fever case-fatality rate in Thailand. Dengue Bull 1999;23:10-7.
8. Monath TP. Dengue: the risks to developed and developing countries. Proc Natl Acad Sci USA 1994;91:2395-400.
9. Sosothikul D, Seksan P, Pongsewalak S, Thisayakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection. Thromb Haemost 2007;97:627-34.
10. Srichaikul T, Nimmanitya S. Hematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol 2000;13:261-76.
11. Suwanik R, Tuchin P, Tuchinda S, et al. Plasma volume and other third space studies in Thai Hemorrhagic Fever. J Med Assoc Thai 1967;50:48-66.
12. Ungchusak K, Thiparat K, Anantapreecha S, Ketkeaw J. Dengue disease in Thailand: Don't let the outbreak going on and on? Siriraj Med J 2007;59:195-6.
13. Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnosis medicine. Bull WHO 1976;53:55-65.
14. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis 2002;35:277-85.
15. nd ed. Geneva: WHO, 1977:12-47.